Kaygee Laboratories Profile
Key Indicators
- Authorised Capital ₹ 13.30 Cr
as on 05-12-2024
- Paid Up Capital ₹ 9.46 Cr
as on 05-12-2024
- Company Age 36 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 26.70 Cr
as on 05-12-2024
- Satisfied Charges ₹ 77.12 Cr
as on 05-12-2024
- Revenue -2.26%
(FY 2021)
- Profit -26.78%
(FY 2021)
- Ebitda 2156.08%
(FY 2021)
- Net Worth 17.80%
(FY 2021)
- Total Assets 17.79%
(FY 2021)
About Kaygee Laboratories
The Corporate was formerly known as Exon Laboratories Private Limited. The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 13.30 Cr and a paid-up capital of Rs 9.46 Cr.
The company currently has active open charges totaling ₹26.70 Cr. The company has closed loans amounting to ₹77.12 Cr, as per Ministry of Corporate Affairs (MCA) records.
Premchand Godha, Prashant Godha, Pranay Godha, and One other member serve as directors at the Company.
- CIN/LLPIN
U24211MH1988PTC045776
- Company No.
045776
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Jan 1988
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kaygee Laboratories?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Premchand Godha  | Director | 25-Sep-2021 | Current |
| Prashant Godha | Director | 01-Jul-2014 | Current |
| Pranay Godha | Director | 07-Oct-1997 | Current |
| Charchit Jain | Director | 18-Jun-2022 | Current |
Financial Performance of Kaygee Laboratories.
Kaygee Laboratories Private Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 2.26% decrease. The company also saw a substantial fall in profitability, with a 26.78% decrease in profit. The company's net worth Soared by an impressive increase of 17.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kaygee Laboratories?
In 2023, Kaygee Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ipca Laboratories LimitedActive 75 years 2 monthsPremchand Godha, Prashant Godha and 1 more are mutual person
Resonance Specialties LimitedActive 35 years 6 monthsPrashant Godha and Charchit Jain are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 17 Jan 2022 | ₹6.70 Cr | Open |
Uti Bank Ltd Creation Date: 26 Mar 2002 | ₹10.00 Cr | Open |
Uti Bank Ltd Creation Date: 07 Mar 2002 | ₹10.00 Cr | Open |
How Many Employees Work at Kaygee Laboratories?
Unlock and access historical data on people associated with Kaygee Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kaygee Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kaygee Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
